Screening, diagnosis, and management of patients with Fabry disease: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference

Publikation: Forskning - peer reviewTidsskriftartikel

DOI

  • Raphael Schiffmann
    Raphael SchiffmannInstitute of Metabolic Disease, Baylor Research Institute, Dallas, Texas, USA. Electronic address: raphael.schiffmann@baylorhealth.edu.
  • Derralynn A Hughes
    Derralynn A HughesDepartment of Haematology, Royal Free London NHS Foundation Trust, & University College London, UK.
  • Gabor E Linthorst
    Gabor E LinthorstDepartment of Endocrinology and Metabolism, Academic Medical Center, Amsterdam, Netherlands.
  • Alberto Ortiz
    Alberto OrtizUnidad de Dialisis, IIS-Fundacion Jimenez Diaz/UAM, IRSIN, Madrid, Spain.
  • Einar Svarstad
    Einar SvarstadDepartment of Occupational Medicine, Haukeland University Hospital, Bergen, Norway; Institute of Clinical Medicine, University of Bergen, Bergen, Norway.
  • David G Warnock
    David G WarnockDivision of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Michael L West
    Michael L WestDepartment of Medicine, Dalhousie University, Halifax, Canada.
  • Christoph Wanner
    Christoph WannerDepartment of Medicine, Division of Nephrology, University Hospital of Würzburg, Würzburg, Germany. Electronic address: wanner_c@ukw.de.
  • Conference Participants (Erik Ilsø Christensen, conference participant)
OriginalsprogEngelsk
BogserieKidney International. Supplement
Vol/bind91
Tidsskriftsnummer2
Sider (fra-til)284-293
Antal sider10
ISSN0098-6577
DOI
StatusUdgivet - feb. 2017

Se relationer på Aarhus Universitet Citationsformater

ID: 109692273